Skip to main content
SpringerLink
Log in

Combined Cognitive Behavioral and Pharmacologic Treatment Strategies: Current Status and Future Directions

  • Chapter
  • First Online:
Avoiding Treatment Failures in the Anxiety Disorders

Part of the book series: Series in Anxiety and Related Disorders ((SARD))

Abstract

This chapter provides a review of the current status of traditional combined treatment strategies: co-application of cognitive-behavioral therapy (CBT) and pharmacotherapy, most typically, with antidepressant or benzodiazepine medications. The success of these strategies, as judged from the perspective of randomized clinical trials and naturalistic case series, will be reviewed and followed by an account of some of the issues and complexities underlying the limited treatment efficacy of this approach. Guidance is provided to clinicians on some of the contextual factors that may hinder CBT efficacy in the context of co-occurring medication treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Abramowitz, J. S. (1997). Effectiveness of psychological and pharmacological treatments for obsessive-compulsive disorder: A quantitative review. Journal of Consulting and Clinical Psychology, 65, 44–52.

    Article  PubMed  Google Scholar 

  • Adler, D., & Price, J. H. (1985). Relation of agoraphobics’ health locus of control orientation to severity of agoraphobia. Psychological Reports, 56, 619–625.

    Article  PubMed  Google Scholar 

  • Anderson, C. A., & Arnoult, L. H. (1985). Attributional style and everyday problems in living: Depression, loneliness, and shyness. Social Cognition, 3, 16–35.

    Article  Google Scholar 

  • Anderson, K. C., & Insel, T. R. (2006). The promise of extinction research for the prevention and treatment of anxiety disorders. Biological Psychiatry, 60, 319–321.

    Article  PubMed  Google Scholar 

  • Bandura, A. (1977). Self-efficacy: toward a unifying theory of behavioral change. Psychological Review, 84(2), 191–215.

    Article  PubMed  Google Scholar 

  • Barlow, D. H., Gorman, J. M., Shear, M. K., & Woods, S. W. (2000). Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: A randomized controlled trial. Journal of the American Medical Association, 283, 2529–2536.

    Article  PubMed  Google Scholar 

  • Basoglu, M., Marks, I. M., Kilic, C., Brewin, C. R., & Swinson, R. P. (1994). Alprazolam and exposure for panic disorder with agoraphobia attribution of improvement to medication predicts subsequent relapse. British Journal of Psychiatry, 164, 652–659.

    Article  PubMed  Google Scholar 

  • Biondi, M., & Picardi, A. (2003). Attribution of improvement to medication and increased risk of relapse of panic disorder with agoraphobia. Psychotherapy and Psychosomatics, 72, 110–111.

    Article  PubMed  Google Scholar 

  • Blomhoff, S., Haug, T. T., Hellström, K., Holme, I., Humble, M., Madsbu, H. P., et al. (2001). Randomised controlled general practice trial of sertraline, exposure therapy and combined treatment in generalized social phobia. British Journal of Psychiatry, 179, 23–30.

    Article  PubMed  Google Scholar 

  • Bouton, M. E. (2002). Context, ambiguity, and unlearning: Sources of relapse after behavioral extinction. Biological Psychiatry, 52, 976–986.

    Article  PubMed  Google Scholar 

  • Broadbeck, C., & Michelson, L. (1987). Problem-solving skills and attributional styles of agoraphobics. Cognitive Therapy and Research, V11(5), 593–610.

    Google Scholar 

  • Brown, T. A., & Barlow, D. H. (1995). Long-term outcome in cognitive-behavioral treatment of panic disorder: Clinical predictors and alternative strategies for assessment. Journal of Consulting Psychology, 63, 754–765.

    Article  Google Scholar 

  • Bruce, S. E., Yonkers, K. A., Otto, M.W., Eisen, J. L., Weisberg, R. B., Pagano, M., et al. (2005). Influence of psychiatric comorbidity on recovery and recurrence in generalized anxiety disorder, social phobia, and panic disorder: A 12-year prospective study. American Journal of Psychiatry, 162, 1179–1187.

    Article  PubMed  Google Scholar 

  • Cain, C. K., Blouin, A. M., & Barad, M. (2003). Temporally massed CS presentations generate more fear extinction than spaced presentations. Journal of Experimental Psychology Animal Behavior Processes, 29, 323–333.

    Article  PubMed  Google Scholar 

  • Cloitre, M., Heimberg, R. G., Liebowitz, M. R., & Gitow, A. (1992). Perceptions of control in panic disorder and social phobia. Cognitive Therapy and Research, 16, 569–577.

    Article  Google Scholar 

  • Cottraux, J., Mollard, E., Bouvard, M., & Marks, I. (1993). Exposure therapy, fluvoxamine, or combination treatment in obsessive-compulsive disorder: One-year followup. Psychiatry Research, 49, 63–75.

    Article  PubMed  Google Scholar 

  • Cottraux, J., Mollard, E., Bouvard, M., Marks, I., Sluys, M., Nury, A. M., et al. (1990). A controlled study of fluvoxamine and exposure in obsessive-compulsive disorder. International Clinical Psychopharmacology, 5, 17–30.

    Article  PubMed  Google Scholar 

  • Cowley, D. S., Ha, E. H., & Roy-Byrne, P. P. (1997). Determinants of pharmacologic treatment failure in panic disorder. Journal of Clinical Psychiatry, 58, 555–561.

    Article  PubMed  Google Scholar 

  • Davidson, J. R. T., Foa, E. B., Huppert, J. D., Keefe, F. J., Franklin, M. E., Compton, J. S., et al. (2004). Fluoxetine, comprehensive cognitive behavioral therapy, and placebo in generalized social phobia. Archives of General Psychiatry, 61, 1005–1013.

    Article  PubMed  Google Scholar 

  • Davis, M., Ressler, K., Rothbaum, B. O., & Richardson, R. (2006). Effects of D-cycloserine on extinction: Translation from preclinical to clinical work. Biological Psychiatry, 60, 369–375.

    Google Scholar 

  • Deacon, B. J., & Abramowitz, J. S. (2005). Patients’ perceptions of pharmacological and cognitive-behavioral treatments for anxiety disorders. Behavior Therapy, 36, 139–145.

    Article  Google Scholar 

  • Emmelkamp, P. M., & Cohen-Kettenis, P. T. (1975). Relationship of locus of control to phobic anxiety and depression. Psychological Reports, 36, 390.

    Article  PubMed  Google Scholar 

  • Falls, W. A., Miserendino, M. J., & Davis, M. (1992). Extinction of fear-potentiated startle: Blockade by infusion of an NMDA antagonist into the amygdala. The Journal of Neuroscience, 12, 854–863.

    Google Scholar 

  • Fava, G. A., Ruini, C., & Rafanelli, C. (2005). Sequential treatment of mood and anxiety disorders. Journal of Clinical Psychiatry, 66, 1392–1400.

    Article  PubMed  Google Scholar 

  • Foa, E. B., Franklin, M. E., & Moser, J. (2002). Context in the clinic: How well do cognitive-behavioral therapies and medications work in combination? Biological Psychiatry, 10, 987–997.

    Article  Google Scholar 

  • Foa, E. B., Liebowitz, M. R., Kozak, M. J., Davies, S., Campeas, R., Franklin, M. E., et al. (2005). Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder. American Journal of Psychiatry, 162, 151–161

    Article  PubMed  Google Scholar 

  • Franklin, M. E., Abramowitz, J. S., Bux, D. A., Zoellner, L. A., & Feeny, N. C. (2002). Cognitive-behavioral therapy with and without medication in the treatment of obsessive-compulsive disorder. Professional Psychology: Research and Practice, 33, 162–168.

    Article  Google Scholar 

  • Franklin, M. E., & Simpson, H. B. (2005). Combining pharmacotherapy and exposure plus ritual prevention for obsessive compulsive disorder: Research findings and clinical applications. Journal of Cognitive Psychotherapy, 19, 317–330.

    Article  Google Scholar 

  • Furukawa, T. A., Watanabe, N., & Churchill, R. (2006). Psychotherapy plus antidepressant for panic disorder with or without agoraphobia. British Journal of Psychiatry, 188, 305–312.

    Article  PubMed  Google Scholar 

  • Gorman, J. M., Kent, J. M., Sullivan, G. M., & Coplan, J. D. (2000). Neuroanatomical hypothesis of panic disorder, revised. American Journal of Psychiatry, 157(4), 493–505.

    Article  PubMed  Google Scholar 

  • Gosselin, P., Ladouveur, R., Morin, C. M., Dugas, M. J., & Baillargeon, L. (2006). Benzodiazepine discontinuation among adults with GAD: A randomized trial of cognitive-behavioral therapy. Journal of Consulting and Clinical Psychology, 74, 908–919.

    Article  Google Scholar 

  • Gould, R. A., Buckminster, S., Pollack, M. H., Otto, M. W., & Yap, L. (1997). Cognitive-behavioral and pharmacological treatment for social phobia: A meta-analysis. Clinical Psychology: Science and Practice, 4, 291–306.

    Article  Google Scholar 

  • Gould, R. A., Otto, M. W., & Pollack, M. H. (1995). A meta-analysis of treatment outcome for panic disorder. Clinical Psychology Review, 15, 819–844.

    Article  Google Scholar 

  • Gould, R. A., Otto, M. W., Pollack, M. H., & Yap, L. (1997). Cognitive behavioral and pharmacological treatment of generalized anxiety disorder: A preliminary meta-analysis. Behavior Therapy, 28, 285–305.

    Article  Google Scholar 

  • Haug, T. T., Blomhoff, S., Hellström, K., Holme, I., Humble, M., Madsbu, H. P., et al. (2003). Exposure therapy and sertraline in social phobia: 1-year follow-up of a randomised controlled trial. British Journal of Psychiatry, 182, 312–318.

    Article  PubMed  Google Scholar 

  • Hegel, M. T., Ravaris, C. L., & Ahles, T. A. (1994). Combined cognitive-behavioral and time-limited alprazolam treatment of panic disorder. Behavior Therapy, 25, 183–195.

    Article  Google Scholar 

  • Heldt, E., Manfro, G. G., Kipper, L., Blaya, C., Isolan, L., & Otto, M. W. (2006). One-year follow-up of pharmacotherapy-resistant patients with panic disorder treated with cognitive-behavior therapy: Outcome and predictors of remission. Behaviour Research and Therapy, 44, 657–665.

    Article  PubMed  Google Scholar 

  • Hoffart, A., & Martinsen, E. W. (1990). Agoraphobia, depression, mental health locus of control, and attributional styles. Cognitive Therapy and Research, 14, 343–351.

    Article  Google Scholar 

  • Hofmann, S. G., Barlow, D. H., Papp, L. A., Detweiler, M. F., Ray, S. E., Shear, M. K., et al. (1998). Pretreatment attrition in a comparative treatment outcome study on panic disorder. American Journal of Psychiatry, 155, 43–47.

    PubMed  Google Scholar 

  • Hofmann, S. G., Meuret, A. E., Smits, J. A. J., Simon, N. A., Pollack, M. H., Eisenmenger, K., et al. (2006). Augmentation of exposure therapy with D-cycloserine for social anxiety disorder. Archives of General Psychiatry, 63, 298–304.

    Google Scholar 

  • Hofmann, S. G., & Smits, J. A. J. (2008). Cognitive-behavioral therapy for adult anxiety disorders: a meta-analysis of randomized placebo-controlled trials. Journal of Clinical Psychiatry, 69, 621–632.

    Article  PubMed  Google Scholar 

  • Hohagen, F., Winkelmann, G., Räsche-Rauschle, H., Hand, I., König, A., Münchau, N., et al. (1998). Combination of behaviour therapy with fluvoxamine in comparison with behaviour therapy and placebo. Results of a multicentre study. British Journal of Psychiatry, 35(Suppl), 71–78.

    Google Scholar 

  • Kampman, M., Keijsers, G. P., Hoogduin, C. A., & Hendriks, G. J. (2002). A randomized, double-blind, placebo-controlled study of the effects of adjunctive paroxetine in panic disorder patients unsuccessfully treated with cognitive-behavioral therapy alone. Journal of Clinical Psychiatry, 63, 772–777.

    Article  PubMed  Google Scholar 

  • Kampman, M., Keijsers, G. P. J., Hoogdiun, C. A. L., & Verbraak, M. J. P. M. (2002). Addition of cognitive-behaviour therapy for obsessive-compulsive disorder patients non-responding to fluoxetine. Acta Psychiatrica Scandinavica, 106, 314–319.

    Article  PubMed  Google Scholar 

  • Kushner, M. G., Kim, S. W., Donahue, C., Thuras, P., Adson, D., Kotlyar, M., et al. (2007). D-Cycloserine augmented exposure therapy for obsessive-compulsive disorder. Biological Psychiatry, 62, 835838.

    Article  PubMed  Google Scholar 

  • Lincoln, T. M., Rief, W., Hahlweg, K., Frank, M., von Witzleben, I., Schroeder, B., et al. (2005). Who comes, who stays, who profits? Predicting refusal, dropout, success, and relapse in a short intervention for social phobia. Psychotherapy Research, 15, 210–225.

    Google Scholar 

  • Lydiard, R. B., Brawman-Mintzer, O., & Ballenger, J. C. (1996). Recent developments in the psychopharmacology of anxiety disorders. Journal of Consulting and Clinical Psychology, 64, 660–668.

    Article  PubMed  Google Scholar 

  • Marks, I. M., Lelliott, P., Basoglu, M., Noshirvani, H., Monteiro, W., Cohen, D., et al. (1988). Clomipramine, self-exposure and therapist-aided exposure for obsessive-compulsive rituals. British Journal of Psychiatry, 152, 522–534.

    Article  PubMed  Google Scholar 

  • Marks, I. M., Stern, R. S., Mawson, D., Cobb, J., & McDonald, R. (1980). Clomipramine and exposure for obsessive-compulsive rituals: I. British Journal of Psychiatry, 136, 1–25.

    Article  PubMed  Google Scholar 

  • Marks, I. M., Swinson, R. P., Basaglu, M., Kuch, K., Nasirvani, H., O’Sullivan, G., et al. (1993). Alprazolam and exposure alone and combined in panic disorder with agoraphobia: A controlled study in London and Toronto. British Journal of Psychiatry, 162, 776–787.

    Article  PubMed  Google Scholar 

  • Mavissakalian, M., & Perel, J. M. (1992). Clinical experiments in maintenance and discontinuation of imipramine therapy in panic disorder with agoraphobia. Archives of General Psychiatry, 49, 318–323.

    PubMed  Google Scholar 

  • Mavissakalian, M. R., & Prien, R. F. (1996). Long-term treatments of anxiety disorders. Washington, DC: American Psychiatric Association.

    Google Scholar 

  • McHugh, R. K., Otto, M. W., Barlow, D. H., Gorman, J. M., Shear, M. K., & Woods, S. W. (2007). Cost-efficacy of individual and combined treatments of panic disorder. Journal of Clinical Psychiatry, 68, 1038–1044.

    Article  PubMed  Google Scholar 

  • Mitte, K., Noack, P., & Hautzinger, M. (2005). A meta-analytic review of the efficacy of drug treatment in Generalized Anxiety Disorder. Journal of Clinical Psychopharmacology, 25, 141–150.

    Article  PubMed  Google Scholar 

  • Mystkowski, J. L., Mineka, S., & Vernon, L. L. (2003). Changes in caffeine states enhance return of fear in spider phobia. Journal of Consulting and Clinical Psychology, 71, 243–250.

    Article  PubMed  Google Scholar 

  • Norberg, M. M., Krystal, J. H., & Tolin, D. F. (2008). A meta-analysis of d-cycloserine and the facilitation of fear extinction and exposure therapy. Biological Psychiatry, 63, 1118–1126.

    Article  PubMed  Google Scholar 

  • Noyes, R. Garvey, M. J., Cook, B., & Suelzer, M. (1991). Controlled discontinuation of benzodiazepine treatment for patients with panic disorder. American Journal of Psychiatry, 148, 517–523.

    PubMed  Google Scholar 

  • Otto, M. W., Hinton, D., Korbly, N. B., Chea, A., Phalnarith, B., Gershuny, B. S., et al. (2003). Treatment of pharmacotherapy-refractory posttraumatic stress disorder among Cambodian refugees: A pilot study of combination treatment with cognitive-behavior therapy vs. sertraline alone. Behaviour Research and Therapy, 41, 1271–1276.

    Article  PubMed  Google Scholar 

  • Otto, M. W., Penava, S. J., Pollack, R. A., & Smoller, J. W. (1996). Cognitive-behavioral and pharmacologic perspectives on the treatment of posttraumatic stress disorder. In M. H. Pollack, M. W. Otto, & J. F. Rosenbaum (Eds.), Challenges in clinical practice: Pharmacologic and psychosocial strategies (pp. 219–260). New York: Guilford Press.

    Google Scholar 

  • Otto, M. W., & Pollack, M. H. (2009 a). Stopping anxiety medication: Therapist guide(2nd ed.). New York: Oxford University Press.

    Google Scholar 

  • Otto, M. W., & Pollack, M. H. (2009 b). Stopping anxiety medication: Workbook (2nd ed.). New York: Oxford University Press.

    Google Scholar 

  • Otto, M. W., Pollack, M. H., & Maki, K. M. (2000). Empirically supported treatments for panic disorder: Costs, benefits, and stepped care. Journal of Consulting and Clinical Psychology, 68, 556–563.

    Article  PubMed  Google Scholar 

  • Otto, M. W., Pollack, M. H., Penava, S. J., & Zucker, B. G. (1999). Cognitive-behavior therapy for patients failing to respond to pharmacotherapy for panic disorder: A clinical case series. Behaviour Research and Therapy, 37, 763–770.

    Article  PubMed  Google Scholar 

  • Otto, M. W., Pollack, M. H., Sachs, G. S., Reiter, S. R., Meltzer-Brody, S., & Rosenbaum, J. F. (1993). Discontinuation of benzodiazepine treatment: Efficacy of cognitive-behavior therapy for patients with panic disorder. American Journal of Psychiatry, 150, 1485–1490.

    PubMed  Google Scholar 

  • Otto, M. W., Smits, J. A. J., & Reese, H. E. (2005). Combined psychotherapy and pharmacotherapy for mood and anxiety disorders in adults: Review and analysis. Clinical Psychology: Science and Practice, 12, 72–86.

    Article  Google Scholar 

  • Pollack, M. H. (2005). The pharmacotherapy of panic disorder. Journal of Clinical Psychiatry, 66(Suppl. 4), 23–27.

    PubMed  Google Scholar 

  • Pollack, M. H., Otto, M. W., Kaspi, S. P., Hammerness, P. G., & Rosenbaum, J. F. (1994). Cognitive-behavior therapy for treatment-refractory panic disorder. Journal of Clinical Psychiatry, 55, 200–205.

    PubMed  Google Scholar 

  • Powers, M. B., Smits, J. A., Leyro, T. M., & Ott, M. W. (2007). Translational research perspectives on maximizing the effectiveness of exposure therapy. In D. C. S. Richard, & D. Lauterbach (Eds.), Handbook of the exposure therapies. Burlington: Academic Press.

    Google Scholar 

  • Powers, M. B., Smits, J. A. J., Otto, M. W., Sanders, C., & Emmelkamp, P. M. G. (2009). Facilitation of fear extinction in phobic participants with a novel cognitive enhancer: A randomized placebo controlled trial of yohimbine augmentation. Journal of Anxiety Disorders, 23, 350–356.

    Article  PubMed  Google Scholar 

  • Powers, M. B., Smits, J. A., Whitley, D., Bystritsky, A., & Telch, M. J. (2008). The effect of attributional processes concerning medication taking on return of fear. Journal of Consulting & Clinical Psychology, 76, 478–790

    Article  Google Scholar 

  • Reiss, S., & McNally, R. J. (1985). The expectancy model of fear. In S. Reiss & R. R. Bootzin (Eds.), Theoretical issues in behavior therapy (pp. 107–121). London: Academic Press.

    Google Scholar 

  • Ressler, K. J., Rothbaum, B. O., Tannenbaum, L., Anderson, P., Grapp, K., Zimand, E., et al. (2004). Cognitive enhancers as adjuncts to psychotherapy: Use of D-cycloserine in phobic individuals to facilitate extinction of fear. Archives of General Psychiatry, 61, 1136–1144.

    Google Scholar 

  • Rief, W., Trenkamp, S., Auer, C., & Fichter, M. M. (2000 Mar–Apr). Cognitive behavior therapy in panic disorder and comorbid major depression. A naturalistic study. Psychotherapy and Psychosomatics, 69(2), 70–78.

    Google Scholar 

  • Roy-Byrne, P., Russo, J., Dugdale, D. C., Lessler, D., Cowley, D., & Katon, W. (2002). Undertreatment of panic disorder in primary care: role of patient and physician characteristics. Journal of the American Board of Family Medicine, 15(6), 443–450.

    Google Scholar 

  • Schmidt, N. B., Wollaway-Bickel, K., Trakowski, J. H., Santiago, H. T., & Vasey, M. (2002). Antidepressant discontinuation in the context of cognitive behavioral treatment for panic disorder. Behaviour Research and Therapy, 40, 67–73.

    Article  PubMed  Google Scholar 

  • Sirey, J. A., Meyers, B. S., Bruce, M. L., Alexopoulos, G. S., Perlick, D. A., & Raue, P. (1999). Predictors of antidepressant prescription and early use among depressed outpatients. American Journal of Psychiatry, 156(5), 690–696.

    PubMed  Google Scholar 

  • Spiegel, D. A., Bruce, T. J., Gregg, S. F., & Nuzzarello, A. (1994). Does cognitive behavior therapy assist slow-taper alprazolam discontinuation in panic disorder. American Journal of Psychiatry, 151, 876–881.

    PubMed  Google Scholar 

  • Stein, D. J.,Versiani, M., Hair, T., & Kumar, R. (2002). Efficacy of paroxetine for relapse prevention in social anxiety disorder. Archives of General Psychiatry, 59, 1111–1118.

    Article  PubMed  Google Scholar 

  • Steketee, G., Chambless, D. L., & Tran, G. Q. (2001 Jan–Feb). Effects of axis I and II comorbidity on behavior therapy outcome for obsessive-compulsive disorder and agoraphobia. Comprehensive Psychiatry, 42(1), 76–86.

    Google Scholar 

  • Taylor, C., King, R., Margraf, J., Ehlers, A., Telch, M., Roth, W., et al. (1989). Use of medication and in vivo exposure in volunteers for panic disorder research. American Journal of Psychiatry, 146(11), 1423–1426.

    Google Scholar 

  • van Balkom, A. J., de Haan, E., van Oppen, P., Spinhoven, P., Hoogduin, K. A., & van Dyck, R. (1998). Cognitive and behavioral therapies alone and in combination with fluvoxamine in the treatment of obsessive compulsive disorder. Journal of Nervous and Mental Disease, 186, 492–499.

    Article  PubMed  Google Scholar 

  • Van Etten, M. L., & Taylor, S. (1998). Comparative efficacy of treatments for post-traumatic stress disorder: a meta-analysis. Clinical Psychology & Psychotherapy, 5(3), 126–144.

    Article  Google Scholar 

  • Walker, J. R., Van Ameringen, M. A., Swinson, R., Bowen, R. C., Chokka, P. R., Goldner, E., et al., (2000). Prevention of relapse in generalized social phobia: Results of a 24-week study in responders to 20 weeks of sertraline treatment. Journal of Clinical Psychopharmacology, 20, 636–644.

    Article  PubMed  Google Scholar 

  • Weilburg, J. B., O’Leary, K. M., Meigs, J. B., Hennen, J., & Stafford, R. S. (2003). Evaluation of the adequacy of outpatient antidepressant treatment. Psychiatric Services, 54, 1233–1239.

    Article  PubMed  Google Scholar 

  • Whittal, M. L., Otto, M. W., & Hong, J. J. (2001). Cognitive-behavior therapy for discontinuation of SSRI treatment of panic disorder: A case series. Behaviour Research and Therapy, 39, 939–945.

    Article  PubMed  Google Scholar 

  • Wilhelm, S., Buhlmann, U., Tolin, D. F., Meunier, S. A., Pearlson, G. D., Reese, H. E., et al. (2008). Augmentation of behavior therapy with D-cycloserine for obsessive-compulsive disorder. Am J Psychiatry, 165(3), 335–341.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Psychology, Southern Methodist University, Dallas, TX, USA

    Jasper A.J. Smits

  2. Harvard University, Cambridge, MA, USA

    Hannah E. Reese

  3. University of Amsterdam, Amsterdam, The Netherlands

    Mark B. Powers

  4. Boston University, Boston, MA, USA

    Michael W. Otto

Authors
  1. Jasper A.J. Smits
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hannah E. Reese
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mark B. Powers
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Michael W. Otto
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jasper A.J. Smits .

Editor information

Editors and Affiliations

  1. Dept. Psychology, Boston University, Beacon St. 648, Boston, 02215, Massachusetts, USA

    Michael Otto

  2. Dept. Psychology, Boston University, Beacon St. 648, Boston, 02215, Massachusetts, USA

    Stefan Hofmann

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Smits, J.A., Reese, H.E., Powers, M.B., Otto, M.W. (2010). Combined Cognitive Behavioral and Pharmacologic Treatment Strategies: Current Status and Future Directions. In: Otto, M., Hofmann, S. (eds) Avoiding Treatment Failures in the Anxiety Disorders. Series in Anxiety and Related Disorders. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-0612-0_5

Download citation

Publish with us

Policies and ethics

Search

Navigation